We are live on ! Find out more
SYNB

Putnam BioRevolution ETF
SYNB

Delisted

SYNB was delisted on the 13th of November, 2025.

Back to rankings

2 hedge funds and large institutions have $3.82M invested in Putnam BioRevolution ETF in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% more capital invested

Capital invested by funds: $3.72M → $3.82M (+$102K)

1.72% less ownership

Funds ownership: 79.53% → 77.81% (-1.7%)

50% less funds holding

Funds holding: 4 → 2 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-2
Holders Change %
-50%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$74.7K
2
UBS Group
UBS Group
Switzerland
-$6.7K
3
Osaic Holdings
Osaic Holdings
Arizona
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
PI
1
Putnam Investments
Massachusetts
$3.41M – – –
Royal Bank of Canada
2
Royal Bank of Canada
Ontario, Canada
$411K -$74.7K -2,793 -16%
UBS Group
3
UBS Group
Switzerland
– -$6.7K -258 Closed
Osaic Holdings
4
Osaic Holdings
Arizona
– -$1K -40 Closed

SYNB Hedge Fund Activity: Q1 2023 in Review

2 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Putnam BioRevolution ETF (SYNB) for Q1 2023, worth a combined $3.82M — up 2.7% from $3.72M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of SYNB and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Royal Bank of Canada, cutting an estimated $74.7K.

  • 2 institutional investors held Putnam BioRevolution ETF (SYNB) as of Q1 2023, down from 4 in Q4 2022.
  • Funds reported $3.82M of Putnam BioRevolution ETF stock for Q1 2023, up 2.7% quarter-over-quarter.
  • 0 funds opened new Putnam BioRevolution ETF positions in Q1 2023 and 2 closed out, a net change of -2 holders.
  • The largest Putnam BioRevolution ETF seller in Q1 2023 was Royal Bank of Canada, an estimated $74.7K sold.

Based on aggregated 13F filings for Q1 2023.